CARDIFF ONCOLOGY INC (CRDF) Stock Analyst Earnings Estimates
NASDAQ:CRDF - Nasdaq - US14147L1089 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 360K -2.70% | 390K 8.33% | 488K 25.13% | 610.164K 25.03% | 328.44K -46.17% | 135.997K -58.59% | 204K 50.00% | 204K | 159.18M 77,929.41% | 425.34M 167.21% | 708.9M 66.67% | |
| EBITDA YoY % growth | -28.41M -52.58% | -39.66M -39.60% | -45.014M -13.50% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -28.86M -51.18% | -39.9M -38.25% | -45.412M -13.81% | -49.822M -9.71% | -58.481M -17.38% | -75.332M -28.81% | -99.764M -32.43% | -146.517M -46.86% | -87.299M 40.42% | 110.16M 226.19% | 350.88M 218.52% | |
| Operating Margin | -8,016.67% | -10,230.77% | -9,305.74% | -8,165.30% | -17,805.65% | -55,392.63% | -48,904.17% | -71,821.83% | -54.84% | 25.90% | 49.50% | |
| EPS YoY % growth | -0.71 36.29% | -0.89 -25.35% | -0.93 -4.49% | -1.00 -7.48% | -0.94 5.67% | -1.16 -23.38% | -1.74 -49.93% | -1.61 7.60% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 -22.40% | -0.25 -11.83% | -0.24 6.94% | -0.25 -0.04% | -0.25 1.90% | -0.32 -28.52% | -0.33 -34.91% | -0.35 -40.70% | -0.36 -41.59% | -0.42 -32.26% | -0.51 -56.25% | -0.62 -76.81% |
| Revenue Q2Q % growth | 74.46K -52.27% | 77.52K -62.19% | 80.58K -50.56% | 83.64K -49.31% | 86.7K 16.44% | 102K 31.58% | 102K 26.58% | 102K 21.95% | 102K 17.65% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -13.033M -26.14% | -13.61M -24.49% | -13.755M -9.64% | -14.185M -12.57% | -14.466M -11.00% | -16.728M -22.91% | -18.258M -32.74% | -19.788M -39.50% | -21.318M -47.36% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.25 -13.64% | -0.28 | 0.03 | 9.22% |
| Q2 2024 Q2Q % growth | -0.26 -4.00% | -0.25 | -0.01 | -2.99% |
| Q1 2024 Q2Q % growth | -0.22 12.00% | -0.25 | 0.03 | 12.85% |
| Q4 2023 Q2Q % growth | -0.21 -5.00% | -0.28 | 0.07 | 25.81% |
| Q3 2023 Q2Q % growth | -0.22 -10.00% | -0.29 | 0.07 | 24.32% |
| Q2 2023 Q2Q % growth | -0.25 -4.17% | -0.26 | 0.01 | 5.44% |
| Q1 2023 Q2Q % growth | -0.25 | -0.23 | -0.02 | -8.45% |
| Q4 2022 Q2Q % growth | -0.20 13.04% | -0.24 | 0.04 | 16.56% |
| Q3 2022 Q2Q % growth | -0.20 -17.65% | -0.27 | 0.07 | 25.73% |
| Q2 2022 Q2Q % growth | -0.24 -41.18% | -0.26 | 0.02 | 6.70% |
| Q1 2022 Q2Q % growth | -0.25 -78.57% | -0.24 | -0.01 | -6.10% |
| Q4 2021 Q2Q % growth | -0.23 -21.05% | -0.18 | -0.05 | -31.35% |
| Q3 2021 Q2Q % growth | -0.17 10.53% | -0.17 | 0.00 | 1.96% |
| Q2 2021 Q2Q % growth | -0.17 66.67% | -0.15 | -0.02 | -11.30% |
| Q1 2021 Q2Q % growth | -0.14 | -0.15 | 0.01 | 6.95% |
| Q4 2020 Q2Q % growth | -0.19 62.75% | -0.14 | -0.05 | -33.05% |
| Q3 2020 Q2Q % growth | -0.19 73.24% | -0.19 | 0.00 | 0.21% |
| Q2 2020 Q2Q % growth | -0.51 35.44% | -0.24 | -0.27 | -108.33% |
| Q4 2019 Q2Q % growth | -0.51 | -0.59 | 0.08 | 13.04% |
| Q3 2019 Q2Q % growth | -0.71 | -0.86 | 0.15 | 17.13% |
| Q2 2019 Q2Q % growth | -0.79 | -0.54 | -0.25 | -46.13% |
| Q1 2019 Q2Q % growth | -1.02 | -1.09 | 0.07 | 6.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 165K 17.02% | 81.6K | 83.4K | 102.21% |
| Q2 2024 Q2Q % growth | 163K 50.93% | 59.925K | 103.075K | 172.01% |
| Q1 2024 Q2Q % growth | 205K 146.99% | 56.1K | 148.9K | 265.42% |
| Q4 2023 Q2Q % growth | 156K 20.00% | 38.25K | 117.75K | 307.84% |
| Q3 2023 Q2Q % growth | 141K 56.67% | 51K | 90K | 176.47% |
| Q2 2023 Q2Q % growth | 108K 20.00% | 51K | 57K | 111.76% |
| Q1 2023 Q2Q % growth | 83K 18.57% | 56.712K | 26.288K | 46.35% |
| Q4 2022 Q2Q % growth | 130K | 74.715K | 55.285K | 73.99% |
| Q3 2022 Q2Q % growth | 90K | 69.564K | 20.436K | 29.38% |
| Q2 2022 Q2Q % growth | 90K 28.57% | 66.096K | 23.904K | 36.17% |
| Q1 2022 Q2Q % growth | 70K | 48.113K | 21.887K | 45.49% |
| Q4 2021 Q2Q % growth | 130K 8.33% | 43.35K | 86.65K | 199.88% |
| Q3 2021 Q2Q % growth | 90K -35.71% | 30.6K | 59.4K | 194.12% |
| Q2 2021 Q2Q % growth | 70K 75.00% | 155.55K | -85.55K | -55.00% |
| Q1 2021 Q2Q % growth | 70K | 155.55K | -85.55K | -55.00% |
| Q4 2020 Q2Q % growth | 120K 33.33% | 33.15K | 86.85K | 261.99% |
| Q3 2020 Q2Q % growth | 140K 180.00% | 33.997K | 106.003K | 311.81% |
| Q2 2020 Q2Q % growth | 40K | 40K | % | |
| Q1 2020 Q2Q % growth | 70K 16.67% | % | ||
| Q4 2019 Q2Q % growth | 90K | 57.63K | 32.37K | 56.17% |
| Q2 2019 Q2Q % growth | 40K | 183.6K | -143.6K | -78.21% |
| Q1 2019 Q2Q % growth | 60K | 176.46K | -116.46K | -66.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2.86% | 0% | 2.49% |
| Revenue | 0% | 10.19% | 1.01% | 12.83% |